Marine carotenoids and oxidative stress

Marine Drugs

Volumn 10, Issue 1, 2012, Pages 116-118

  Riccioni, Graziano ^a,b  

^a SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cardiovascular disease; Coronary artery disease; Marine carotenoids; Oxidative stress; Prevention; Reactive oxygen species

Indexed keywords

ASCORBIC ACID; ASTAXANTHIN; BETA CAROTENE; CAROTENOID; CATALASE; FUCOXANTHIN; GLABRIDIN; HEME OXYGENASE 1; LYCOPENE; OLIVE OIL; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); SUPEROXIDE DISMUTASE; THIOREDOXIN; XANTHOPHYLL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DRUG SYNTHESIS; EXERCISE; FRUIT; HEART INFARCTION; HUMAN; MEDITERRANEAN DIET; OXIDATIVE STRESS; PRIMARY PREVENTION; RED WINE; REVIEW; RISK REDUCTION; STROKE; VEGETABLE;

EID: 84856279936     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md10010116     Document Type: Review

References (10)

1. Il'yasova, D.; Ivanova, A.; Morrow, J.D.; Cesari, M.; Pahor, M. Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. Atherosclerosis 2009, 204, 309-314.
2. Riccioni, G. Carotenoids and cardiovascular disease. Curr. Atheroscl. Rep. 2009; 11, 434-439.
3. Riccioni, G.; D'Orazio, N.; Franceschelli, S.; Speranza, L. Marine carotenoids and cardiovascular risk markers. Mar. Drugs 2011, 9, 1166-1175.
4. Houston, M.C. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther. Adv. Cardiovasc. Dis. 2010, 4, 165-183.
5. Chuang, G.C.; Yang, Z.; Westbrook, D.G.; Pompilius, M.; Ballinger, C.A.; White, C.R.; Krzywanski, D.M.; Postlethwait, E.M.; Ballinger, S.W. Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297, 209-216.
6. Gori, T.; Nzel, T.M. Oxidative stress and endothelial dysfunction: therapeutic implications. Ann. Med. 2011, 43, 259-272.
7. Lee, S.; Park, Y.; Zuidema, M.Y.; Hannink, M.; Zhang, C. Effects of interventions on oxidative stress and inflammation of cardiovascular diseases. World J. Cardiol. 2011, 3, 18-24.
8. Seo, H.; Oh, H.; Park, H.; Park, M.; Jang, Y.; Lee, M. Contribution of dietary intakes of antioxidants to homocysteine-induced low density lipoprotein (LDL) oxidation in atherosclerotic patients. Yonsei. Med. J. 2010, 51, 526-333.
9. Bhatt, D.L. Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. Am. J. Cardiol. 2008, 101, 4-13.
10. Fassett, R.G.; Coombes, J.S. Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar. Drugs 2011, 9, 447-465.